Generic Amantadine
Product: Generic Symmetrel
Drug Name: Amantadine
Packaging Type: Blister strip of 10 x 100mg capsules
| Generic Amantadine Prices |
| 30 tablets of Generic Amantadine |
US$15.00 |
 | |
| 60 tablets of Generic Amantadine |
US$27.00 |
 | |
| 100 tablets of Generic Amantadine |
US$40.00 |
 | |
| 300 tablets of Generic Amantadine |
US$105.00 |
 | |
What is Generic Amantadine?
Amantrel is Amantadine HCl (Generic Symmetrel) and is used for the prevention and treatment of bird flu and other various strains of influenza A virus. Amantadine Hydrochloride is also indicated in the treatment of parkinsonism (Parkinson's disease) and drug-induced extrapyramidal reactions.
Amantadine (Generic Symmetrel)
Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride capsules are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions.
Generic Amantadine & Influenza A Prophylaxis
Amantadine hydrochloride capsules are indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection when early vaccination is not feasible or when the vaccine is contraindicated or not available. In the prophylaxis of influenza, early vaccination on an annual basis as recommended by the Centers for Disease Control's Immunization Practices Advisory Committee is the method of choice. Because amantadine does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. Following vaccination during an influenza A outbreak, amantadine prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response.
Generic Amantadine & Influenza A Treatment
Amantadine hydrochloride capsules are also indicated in the treatment of uncomplicated respiratory tract illness caused by influenza A virus strains especially when administered early in the course of illness. There are no well-controlled clinical studies demonstrating that treatment with amantadine hydrochloride will avoid the development of influenza A virus pneumonitis or other complications in high risk patients.
There is no clinical evidence indicating that amantadine is effective in the prophylaxis or treatment of viral respiratory tract illnesses other than those caused by influenza A virus strains.
Generic Amantadine & Parkinson's Disease/Syndrome
Amantadine is indicated in the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication. It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis. In the treatment of Parkinson's disease, amantadine is less effective than levodopa, (-)-3-(3,4-dihydroxyphenyl) L-alanine, and its efficacy in comparison with the anticholinergic antiparkinson drugs has not yet been established.
Generic Amantadine & Drug-induced Extrapyramidal Reactions
Amantadine hydrochloride is indicated in the treatment of drug-induced extrapyramidal reactions. Although anticholinergic-type side effects have been noted with amantadine when used in patients with drug-induced extrapyramidal reactions, there is a lower incidence of these side effects than that observed with the anticholinergic antiparkinson drugs.
|